Wells Fargo upgraded NeuroPace to Overweight from Equal Weight with a price target of $20, up from $16.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NPCE:
- Neuropace, Inc.’s New Economy & Political Environment Risk – A Cause for Worry?
- NeuroPace price target raised to $13 from $9 at Morgan Stanley
- NeuroPace price target raised to $20 from $17 at Lake Street
- NeuroPace sees FY24 revenue $73M-$77M, consensus $74.6M
- NeuroPace reports Q4 EPS (23c), consensus (31c)